5mg/2ml semaglutide Real progress. Real results. Every journey starts with a single step, and this transformation is proof that consistency pays off. 💪 Swipe to see the difference and imagine what's possible for you Hims Launches GLP-1 Injections, Shoots

Cardiovascular Health GLP1 has been shown to reduce the risk of major adverse cardiovascular events, such as heart attack and stroke, in individuals with type 2 diabetes and high cardiovascular risk

Clodi K, Asgary Z, Zhao S, Younes M, Wimmer D, Cabanillas F, Andreeff M , Younes A

Semaglutide is a GLP-1 receptor agonist used for weight loss and type 2 diabetes

From a dermatologists point of view, the addition of GHK-Cu plays a supportive role by repairing the biological components of the skin

Weight loss by calorie restriction does not alter appetite-regulating gut hormone responses from perfused rat small intestine

Ensure that all the injections are done in a sterile environment to reduce the risk of infection